Create a narrative

Arcturus Therapeutics Holdings Community

NasdaqGM:ARCT Community

1 Narratives written by author
0 Comments on narratives written by author
47 Fair Values set on narratives written by author

Create a narrative

Arcturus Therapeutics Holdings

AN

AnalystConsensusTarget

Consensus Narrative from 10 Analysts

KOSTAIVE Approval And Upcoming Vaccine Trials Will Open New Markets

Key Takeaways European approval of the mRNA COVID-19 vaccine could significantly boost sales through broader market access in 31 countries. Progress in cystic fibrosis treatment and pandemic influenza vaccine development could create new revenue streams and address unmet medical needs.

US$70.30

FV

82.2% undervalued

26.36%

Revenue growth p.a.

0

0

33

1 day ago